✦ LIBER ✦

SORAFENIB THERAPY IN THE MANAGEMENT OF ADVANCED RENAL CELL CARCINOMA WITH BRAIN METASTASES: RESULTS FROM THE ARCCS EXPANDED ACCESS PROGRAM

✍ Scribed by C.A. Henderson; R.M. Bukowski; W.M. Stadler; J.P. Dutcher; T.L. Kindwall-Keller; S.J. Hotte; K.W. Logie; B.P. Baltz; K. Wilson; R.A. Figlin

Book ID: 119619025
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 74 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(08)60695-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

858 SAFETY ANALYSIS OF THE ADVANCED RENA

858 SAFETY ANALYSIS OF THE ADVANCED RENAL CELL CARCINOMA SORAFENIB (ARCCS) STUDY, AN EXPANDED ACCESS PROGRAM

✍ R. Bukowski; R. Figlin; W. Stadler 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Safety and efficacy results of the advan

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

✍ Walter M. Stadler; Robert A. Figlin; David F. McDermott; Janice P. Dutcher; Jenn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

## Abstract ## BACKGROUND: The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) program made sorafenib available to patients with advanced renal cell carcinoma (RCC) before regulatory approval. ## METHODS: In this nonrandomized, open‐label expanded access program, 2504 patients from the United St

7132 Safety and efficacy of sorafenib in

7132 Safety and efficacy of sorafenib in patients with advanced renal cell carcinoma (RCC) with varying histologies: results from the phase 3, open access study of sorafenib in European patients with advanced RCC (EU-ARCCS)

✍ Bokemeyer, C.; Gore, M.; Bracarda, I.; Richel, N.; Staehler, D.; von der Maase, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

7130 Efficacy and safety of sorafenib in

7130 Efficacy and safety of sorafenib in patients with advanced clear-cell renal-cell carcinoma (RCC) with bone metastases: results from the phase III target study

✍ Bukowski, R.; Eisen, T.E.; Stadler, W.S.; Szczylik, C.S.; Oudard, O.S.; Siebels, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Prognostic Factors of Survival for Patie

Prognostic Factors of Survival for Patients With Metastatic Renal Cell Carcinoma With Brain Metastases Treated With Targeted Therapy: Results From the International Metastatic Renal Cell Carcinoma Database Consortium

✍ Vickers, Michael M.; Al-Harbi, Hulayel; Choueiri, Toni K.; Kollmannsberger, Chri 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 314 KB

7147 POSTER The REACT Expanded-access Pr

7147 POSTER The REACT Expanded-access Program of Everolimus in Patients With Metastatic Renal Cell Carcinoma Refractory to VEGF-targeted Therapy: Subgroup Analyses by Prior Therapy

✍ Larkin, J.; Blank, C.; Bono, P.; Kim, D.; Panneerselvam, A.; Grünwald, V. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB